Yasutsugu Asai, Satoshi Kobayashi, Kazumasa Shiraishi, Masato Enomoto, Tomomi Hamaguchi, Yuichiro Tozuka, Taito Fukushima, Shun Tezuka, Makoto Ueno, Junji Furuse. "Predictive factors for the efficacy of nal-IRI + 5FU/LV therapy in patients previously treated with conventional irinotecan.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.737